Although previous studies have shown the role of insulin/IGF1 signaling and the downstream molecules in HCC development, the possibility of the effect of steatosis and surrounding hepatocellular damage could not be excluded in these studies. The gene discussed is IGF1; the disease is hepatocellular carcinoma.